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Abstract

Introduction

In this study, we evaluated the effect of PEO/
PBT proportion on the behavior of a range of PEO/
PBT segmented copolymers (Polyactive) during subcutaneous and intrabony implantation in the rat. It was
demonstrated that varying the PEO proportion affected
degradation, calcification and bone-bonding.
The
PEO/PBT 70/30 and 60/40 showed extensive degradation after 1 year, PEO/PBT 55145 an intermediate deg radation, and the 40/60 and 30170 copolymers showed
little and hardly any degradation respectively. PEO
content also affected the degree of calcification .
PEO/PBT 70/30 showed extensive and early calcification whereas almost no calcification was seen with
PEO/PBT 30170. Since calcified sites at the periphery
of the polymeric implants were locations of preference
for bone-bonding to occur, PEO/PBT proportion also
influenced bone/PEO/PBT interactions . The materials
with the highest PEO content most frequently showed
morphological indications of bone-bonding , while the
material with 30 % PEO showed no bone/biomaterial
contact.
The differences in bone-bonding activity
were also reflected by the occurrence of an electron.
dense zone at the bone-biomaterial interface which was
morphologically similar to that observed for calcium
phosphate ceramics.

For alloplastic materials , bone-bonding is a
property that has been mainly attributed to certain
calcium phosphate ceramics [6, 19, 21, 24] and so
called glass ceramics and Bio glass [20, 22]. Furthermore, specific surface reactions on titanium might also
place this material into the category of bone-bonding
biomaterials [16]. Each of these materials has a high
elastic modulus and the glasses and ceramics generally
have a low fracture toughness. Evidently, the scope
of clinical application of bone-bonding biomaterials
would be widened by the availability of materials with
a lower elastic modulus, for instance elastomeric polymers.
Until recently no bone-bonding polymers were
available and most efforts directed towards obtaining
materials with a lower elastic modulus than glasses
and ceramics has led research groups to pursue the
manufacturing of bone-bonding composites. In these
composites, the bone-bonding glasses or ceramics are
added as a filler [10] or a coating to a polymeric or
metallic substrate [15, 31, 34] and this approach
seems to be successful. However, the scope of bonebonding biomaterials would be even further widened
by the availability of a polymer which possesses bonebonding properties without the addition of bonebonding agents.
Recently Bakker et al. [2 , 3, 4] described that a
specific Poly(ethylene oxide hydantoin) Poly(butylene
terephthalate) segmented copolymer (HPEO/PBT 551
45), with a 55/45 distribution in weight between the
two segments, possessed properties that fitted in the
bonding osteogenesis theory of Osborn and Newesly
[25]. When implanted in a porous form near the bony
middle ear bulla of the rat, the HPEO/PBT 55/45 copolymer (also known under the trade name Polyactive)
showed an intimate contact with bone without an intervening fibrous tissue layer [2]. Furthermore , bone
deposition and ingrowth started both from the periphery and center of pores which fitted Osborn's "bioactive" materials in contrast to the so called "biotolerated" materials which are characterized by distance
osteogenesis. Another indication of the bone-bonding
capacity of the HPEO/PBT 55/45 copolymer was its
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similarity at the bone/biomaterial interface as compared to hydroxyapatite ceramics [3]. An electron
dense layer was found that showed continuity with the
lamina limitans of bone [29] and was similar in morphology to the bonding zone or electron dense layer
observed at the hydroxyapatite/bone interface [7 , 12,
17, 27]. By several authors, this layer is considered
to play an important role in the bone bonding process.
Recent studies have investigated the interactions
with bone, of dense HPEO/PBT 55145 in comparison
with PEO/PBT 55145 , lacking the hydantoin segment ,
together with two calcium phosphate ceramics and silicone rubber [8, 9]. It was reported that both HPEO/
PBT 55145 and PEO/PBT 55145 bonded with bone as
did the calcium phosphate ceramics. During pull out
studies, the bonding strength at the bone/biomaterial
interface exceeded the internal strength of both polymers and ceramics. This study demonstrated that hydantoin was not necessary for bone-bonding of the copolymer and can therefore be omitted in future studies. In addition, there seemed to be a relationship
between the calcification of the polymer's surface and
the occurrence of bone-bonding . At such areas , calcium phosphate crystals were seen to penetrate into the
polymer , forming a continuity between the crystals in
bone and the polymer, partially explaining the bonebonding mechanism.
·
Since calcification of the (H)PEO/PBT 55 /45
copolymer is possibly related to the PEO segment of
the polymer , which as Polyether depending on its molecular weight, would be able to absorb calcium ions
[32], we decided to investigate the effects of variation
in PEO/PBT proportion . Special emphasis was placed
on the assessment of degradation, calcification and
bone-bonding, using light microscopy, scanning transmission electron microscopy, X-ray microanalysis and
image analysis. The PEO/PBT copolymers, varying in
PEO proportion from 30% to 70%, were implanted in
the form of dense blocks into the tibia and subcutis of
the rat. Calcification was also quantitatively assessed
on porous films during subcutaneous implantation in
the same anir.tal.

subcutaneously after dorsal incisions . Blocks were
also implanted into the rat tibia, no press fit procedure
was used and the implants were loosely inserted into
the created defect (greater than ± 2 mm). Male Wistar rats of 180-200 grams body weight were used. As
post-operative evaluation intervals, we chose 3 weeks,
6 weeks, 3 months, 6 months and 12 months. For
each PEO/PBT proportion and implant type (blocks
and films), 4 implants were used per implantation site
and interval , thus representing a total of 200 blocks
and 100 films distributed over 50 animals.
Evaluation techniques
As evaluation techniques , we used light microscopy , scanning electron microscopy (Philips 525),
transmission electron microscopy (Philips 201 , 400,
410), back-scattered electron microscopy , X-ray
microanalysis (TN 2000, Voyager) and image analysis
(Vidas) . Both decalcified and non-decalcified material
were studied. All specimens were fixed in glutaraldehyde and those destined for transmission electron microscopy were post-fixed in 1 % osmium tetroxide .
The films (4 per type and interval) were only analyzed
by light microscopy and alizarin red staining (indicative for calcium) wh ile in the case of the blocks , two
were used for light microscopy, one for scanning and
one for transmission electron microscopy. Back-scattered electron microscopy was mostly performed on
either Epon or glycol methacrylate embedded blocks
obtained after sectioning and on corresponding sections , all sputter-coated with carbon. A more elaborate description of the techniques has been reported in
earlier publications [8].
Determination of calcification
For each implant type and postoperative interval , 4 films were sectioned in 2 µm sections with a
LKB Ultracut 2000 . Subsequently, 5 sections were
analyzed by a Vidas image analysis system for the
presence of calcium, based on alizarin red staining.
The polymers were visualized by sudan black staining
and/or polarized light and the tissue morphology and
boundaries were assessed using a toluidine blue stain.

Materials and Methods

Results

Implant materials
Five different PEO/PBT block copolymers differing in PEO/PBT proportion (PEO/PBT: 70/30,
60/40, 55145, 40160 and 30170) were used. All polymers were obtained through HC Implants BV (Leiden,
The Netherlands). The polymers were in the form of
dense smooth blocks (1.5 x 1.5 x 1.5 mm) with the exception of the 55145 and 30/70 which at the time of
the study were only available in a cylindrical form of
similar dimensions. Furthermore , all materials were
also used as porous films. The molecular weight of
the individual PEO segments was 1000 Dalton (D).
Implantation site and procedure
Both blocks and porous films were implanted

Subcutaneous implantation
General tissue reactions: All blocks showed
similar reactions concerning the surrounding fibrous
tissue when studied by light microscopy. Initially (3
weeks) the blocks were partially surrounded by a
loosely arranged fibrous tissue, incorporating some inflammatory cells (Fig. 1). After longer implantation
times, a thin zone of dense fibrous tissue with collagen
fibers running parallel to the surface was observed.
Fibroblasts within the capsule assumed a similar orientation . Although large areas near the implant surface
lacked the presence of inflammatory cells, both macrophages and multinucleated cells could be observed at
some locations . The use of scanning and transmission
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electron microscopy confirmed these light microscopical findings. It should be emphasized that the above
description of the tissue surrounding the implant largely refers to those implants with their surface predominantly intact. After one year such an intact surface
was only observed for the PEO/PBT 30/70 and 40/60
copolymers. All other PEO/PBT proportions showed
a clear alteration of the implant structure.
Implant degradation: The first indications of
a change in implant structure were observed for the
PEO/PBT 70/30 copolymer. This polymer already
showed degradation into relatively large fragments
three weeks following implantation, which was most
clearly observed by scanning electron microscopy .
Due to the relatively large size of the individual frag ments most of the implant/tissue interface of this copolymer was still composed of a morphologically intact polymer surface. At 6 weeks the degradation of
PEO/PBT 70/30 had progressed and PEO/PBT 60/ 40
showed the first signs of fragments detaching from its
surface. All other PEO/PBT proportions were still
generally intact, except for crack formation at their
surface in a confined zone of approximately 10-100
µm thickness . After 3 months , both the 70/30 and
60/40 proportion showed extensive fragmentation
throughout and fibrous tissue had filled the interfragment space. At this point in time, the PEO/PBT 55145
also showed extensive crack formation and detachment
of fragments from the implant surface although the implant outline was still largely intact. Crack formation
in the PEO/PBT 40/60 had proceeded but fragment detachment was not yet apparent. The PEO/PBT 30/70
did not reveal significant changes as compared to the 6
weeks period. In the 6 month and 1 year periods,
fragmentation had continued for the PEO/PBT 70/30,
60/40 and 55/45 copolymer causing a smaller average
particle size in the course of time. For the PEO/PBT
70/30 proportion , fragmentation was so extensive that
the implants were difficult to retrieve after 1 year.
The PEO/PBT 40/60 and 30/70 did not show a significant deviation from the 3 month period with exception
of the occurrence of a single deep crack in one of the
40/60 implants after one year. Figures 2a-d show the
sit uation for the various PEO/PBT proportions after
long term implantation. With exception of the 1 year
PEO/PBT 70/30, the original contours of the implants
could still be observed despite the fact that tissue had
grown into the interfragment space. This indicated
that the disappearance of implant material from the actual implantation site, was either by cellular transport
or actual resorption. Light microscopical surveys of
general degradation are shown in Figures 3a-c.
Cellular reactions during degradation: The
degradation found for the different PEO/PBT proportions had major consequences for the tissue that surrounded the implants and penetrated into the interfragme nt space. Light microscopy revealed that , in the
early stages of fragment detachment , phagocytes were
present near the implant surface with implant particles

Figure 1. Light micrograph of a dense 70/30 PEO/
PBT implant (I) after 6 weeks of subcutaneous implantation. Bar = 150 µm.
in their cytoplasm. As fragmentation continued, these
cells were also seen in the interfragment spaces. The
more extensive fragmentation became, the more prominent these cells were and the higher their extent of
cytoplasmic loading. Eventually, the phagocytes in
the heavily degrading PEO/PBT proportions assumed a
foam cell appearance. Transmission electron microscopy showed the extent of phagocytosis of implant material even more clearly (Fig. 4). In spite of the heavy
loading of these cells with implant fragments, their
general morphology remained relatively normal (Fig.
5). The nucleus was always intact and all cell organelles were present. The high amount of, frequently
dilated, rough endoplasmic reticulum and mitochondria suggested a high metabolic activity. The orientation and morphology of fragments in the cell cytoplasm sometimes suggested that fragmentation would
even continue within the cytoplasm.
Subcutaneous calcification
General observations: When investigating the
polymers, it was observed that zones were present in
the polymer that stained positive during alizarin red
The
staining, indicating the presence of calcium.
presence of both calcified spots and larger calcified
areas with quite frequently spots at their internal
periphery (Fig. 6) suggested that calcification started
by focal points gradually leading to larger calcified
areas. Calcified areas were also clearly visible using
scanning electron microscopy combined with single
spot analysis or with backscatter electron microscopy
(Figures 7a-d; at color plate page 33). The composition of these calcified areas will be further elucidated
below when discussing the interactions of the PEO/
PBT copolymers with bone. Calcification was more
prominent with increasing PEO content and no calcification was observed with the 30/70 copolymer.
Quantification of calcification: Since quantitative evaluation of the calcification in the blocks was
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difficult to perform, we decided to use the porous
polymer films for quantitation. In general, the films
showed an apparently faster degradation than the
blocks . Due to this rapid degradation, it was no longer possible to retrieve the 70/30 films after periods
longer than 3 months. The polymers were well recognized by sudan black staining and calcification was assessed by alizarin red staining (Fig. 8). The results,
obtained after image analysis, are shown in Fig. 9
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Figure 2 (facing page, left). Scanning electron micrographs of different dense PEO/PBT implants after
subcutaneous implantation.
Sometimes the porous
film is also visible. I = dense implant, p = porous
film. a) PEO/PBT 30/70, 1 year after implantation
showing no noteworthy signs of degradation. Bar =
0.63 mm. b) PEO/PBT 40160, only shows confined
crack formation after 1 year of implantation. Bar =
0.56 mm. c) PEO/PBT 60140 with prominent fragmentation, 1 year after implantation. Bar = 0.67 mm.
d) PEO/PBT 70/30, characteristically showed extensive fragmentation and disappearance of bulk material,
6 months after implantation. Bar = 0.69 mm.
Figure 3 (facing page right). Light micrographs of
increasing stages of fragmentation during subcutaneous
implantation. C = calcified area (alizarin red staining). a) PEO/PBT 55/45 after 1 year of implantation.
The first signs of fragmentation are seen in the form
of crack formation of the interface (arrows). Bar =
300 µm. b) PEO/ PBT 60/40 implanted for 1 year
showing the second stage of fragmentation, more extensive surface erosion leading to detachment of implant fragments (arrows). Bar = 300 µm. c) PEO/
PBT 70/30 after 1 year of implantation showing extensive fragmentation throughout the polymer. Bar =
300 µm.
Figure 4 (at right, top). Phagocytes near the implant
surface. (I) heavily loaded with polymer fragments
(arrows). Transmission electron micrograph. Bar =
3.1 µm.
Figure 5 (at right, middle). A more detailed micrograph of the cytoplasm of a cell that phagocytosed
PEO/PBT 70/30 (arrows) 6 months after subcutaneous
implantation. Note the normal morphology of the cell
organelles. Bar = 0.94 µm.
which indicates that more PEO will lead to increased
calcification. This seems to suggest that an increase
in PEO content will also lead to earlier calcification.
In correspondence with the blocks, no calcification
was found for the 30/70 copolymer. It was interesting
to note that with the exception of the PEO/PBT 40/60
copolymer, none of the implanted films showed significant calcification at the 3 month period. In contrast,
calcification could still be found with the blocks at this
stage.
Implantation into the tibia

6

The degradation behavior of the PEO/PBT copolymers has already been discussed in the Subcutaneous implantation section above. The mechanism of
degradation in bone did not significantly deviate from
that in the subcutaneous implantation site, although it
generally seemed less prominent, therefore degradation will not be further discussed in this section and
the results will be confined to bone/biomaterial interacti ons.

Figure 6. The interfacial zone of a PEO/PBT 55145
with fibrous tissue after 1 year of implantation. Extensive calcification (C) is found near the implant surface with spot-like calcification seen at greater distances (arrow). Bar = 60 µm.
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Table 1. Degradation of PEO/PBT copolymers after 3 and 6 weeks (w), and 3, 6, and 12 months (m).

PEO/PBT

3w

6w

3m

6m

12m

70/30

+++

+++

++++

++++

+++++

+++

++++

++++

+++

+++

60/40

+

++

55/45

-

+

++

40/60

-

-

+

+

-

-

30/70

+
++
+++
++++
+++++

+/++

-

Superficial crack formation
Crack formation within bulk of material
Fragments detaching from surface
Fragmentation into large particles
Degradation into smaller particles
Extensive degradation

Light microscopical evaluation of the various
PEO/PBT implants showed rather similar reactions.
All implants were covered by fibrous tissue, bone
marrow, and bone. The bone was of a lamellar type
and after longer implantation times, large parts of the
polymer were covered by this type of tissue (Fig. 10).

after implantation. The X-ray maps provided in Fig.
11 demonstrated that the tissue surrounding the
implant in the marrow cavity was indeed composed of
bone, as indicated by the presence of calcium and
phosphorus signals. A higher magnification of the
area near the cortex, combined with X-ray map (Figures 12a-c; at color plate on page 33), showed that the
bone was in continuity with what seemed to be calcified spots in the implant material. Analysis of these
areas by transmission electron microscopy showed calcified areas throughout the polymer and near bone.
Higher magnifications demonstrated that such spots
were composed of needle-like crystals. The similarity
between the crystals in the polymer and those in bone
is stressed by Figures 13a and b, which show a calcified area in the polymer surface opposed to bone.
Furthermore, an electron dense zone could sometimes
be seen at the interface in these locations.

Evaluation of non-decalcified material: Analysis of the bone/biomaterial interface by scanning and
transmission electron microscopy and backscatter electron microscopy in combination with X-ray microanalysis showed that, with exception of the PEO/PBT
30/70 copolymer, all copolymers had areas of intimate
bone contact. With PEO/PBT 30/70 areas of contact
were present at the light microscopical level, but this
observation was never confirmed by electron microscopy. Electron microscopy always showed areas of
non-calcified tissue either composed of cellular or
collagenous material. Concerning the other polymers,
it should be emphasized that the data were suggestive
of an increase in the incidence of intimate contact, in
time and in quantity, with increasing PEO content.
However, due to the relatively small number of
implants investigated, this presumption could not be
proven. The general appearance of the bone-polymer
interface is illustrated by the use of back-scattered
electron microscopy in Figures 1 la-c (on color plate,
at page 33) which shows a polished, non-decalcified,
Spurr embedded PEO/PBT 60/40 implant, 3 months

Analysis of decalcified material: Study of the
decalcified bone/PEO/PBT copolymer interface was
predominantly performed with transmission electron
microscopy . Although the morphology of the interface
showed some variation, an interesting structure was
seen at the interface of all materials except for the
30/70 PEO/PBT copolymer. This latter material never
showed a clear contact with bone and sometimes a
non-calcified lamellar structure was seen interposed
between bone and the polymer (Fig. 14a). At the
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calcification of Polyactive

9
-+60

30(70

subcutaneous implantation
40/60
-o- 55/45 -+- &0140

-t.-

- · - 70(3C

(%)

Weeks

Figures 7, 11, & 12 are on color plate, page 33.
Figure 8 (top left). Light micrograph showing a
porous PEO/PBT 60/40 film after 6 weeks of implantation. The major part of the implant fragments are
calcified as indicated by the Alizarin red staining
(arrows). Bar = 250 µm.
Figure 9 (middle left). Diagram showing the calcification in different PEO/PBT proportions as a percentage of total PEO/PBT surface.
Figure 10 (bottom left). Light micrograph showing a
general view of a decalcified PEO/PBT 60/40 interface
with bone after 6 months. Bar = 60 µm. I =implant,
b =bone.
Figure 13 (above). a) Transmission electron micrograph of the non-decalcified PEO/PBT 60/40 interface
with bone after 3 months. Note the presence of small
needle-like crystals in both the bone (b) and the implant (I). Note the electron dense zone at the interface
(arrows). Bar = 1.1 µm. b) Spot analysis (at *)
shows the presence of Ca and P throughout the
polymer. Copper peaks are from the grid.
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bone/biomaterial interface of all materials with a PEO
content of 40% per weight or more, an electron dense
deposit was encountered. In the case of the PEO/PBT
40/60, this zone was composed of focal floccular material but it was unclear whether it was located on the
surface or also in the implant material (Fig. 14b). A
similar structure was found with the PEO/PBT 55/45
material, however, it was more continuous and frequently had a multilayered structure above (Fig. 14c).
The PEO/PBT 60/40 mostly lacked the floccular deposit found with the 55/45 and 40/60 materials, here
only a prominent multilayered structure was seen (Fig.
14d). A similar structure was observed with the PEO/
PBT 70/30 copolymer (Fig. 14e). With the latter type
of material, it was characteristic that part of the multilayered electron dense structure was located in the actual polymer.
This latter phenomenon was never
clearly demonstrated for the other PEO/PBT proportions .

presence of relatively high amounts of material that
had already been phagocytosed. In general, cell morphology remained intact and, in spite of the sometimes
extensive fragmentation, no local inflammatory response was observed other than the presence of the
phagocytosing cells. These data deviated from findings described for polylactide and associated polymers, where an extensive inflammatory reaction was
reported during the degradation stage [4, 28] . Since
substantial degradation of the PEO/PBT copolymers
can occur, it will be necessary to further analyze the
degradation route and products. However, the experimental data and those in the literature do not indicate
any adverse effects associated with degradation of
these copolymers [l, 4, 5, 18, 26, 30, 35].
Varying the PEO/PBT ratio did not only influence degradation rate but also the calcification of the
polymer. Calcification of polymers is a well known
phenomenon and several studies have been dedicated
to preventing this. Part of those studies indicate that
PEO or PTMO homopolymers with a molecular weight
of 1000 D showed a peak in calcium absorption [32].
The molecular weight of the PEO used in this study
was 1000 D and as the calcification rate increased with
PEO content, it is likely that calcification of the
PEO/PBT copolymer is indeed related to calcium absorption by the PEO fragment. It was interesting to
note that the quantitative assessment of calcification in
the porous films indicated that it was a reversible
process, at least in soft tissue. With the exception of
the PEO/PBT 40/60, which apparently shows an overall delayed and less distinct reaction, no significant
calcification was found at implantation periods of
three months and more. It should be emphasized,
however , that the quantitation was only based on porous films · after subcutaneous implantation and other
implant shapes and/or implantation sites may show different calcification patterns. This was actually confirmed by the fact that extensive calcification could
still be found in the dense blocks after longer implantation times irrespective of the fact whether they were
implanted subcutaneously or in bone. Although calcium absorption by the PEO segment must play a role in
the calcification it is still not clear how the precipitation of calcium phosphate occurs and why it occurs
at specific sites, such as just beneath the surface of the
implant material. The data presented in the current
study suggest that calcification initially occurs by the
formation of needle-shaped calcium phosphate crystals , not unlike hydroxyapatite, in mineralization nodules. In later stages, the merging of mineralization
nodules might lead to the larger calcified areas which
were frequently observed near the surface or in the
center of the dense blocks.
Calcification near the surface of the polymers
plays an important role in the bone-bonding process.
This is stressed by the fact that our current data support the view that PEO/PBT 30170, which shows no
significant calcification, never revealed an intimate

Discussion
Varying the PEO/PBT proportion of PEO/PBT
copolymer had several effects. First, PEO/PBT proportion directly influenced the degradation rate of the
copolymer. The fastest degradation rate was observed
for the PEO/PBT 70/30 copolymer, which was almost
completely degraded after 1 year, while the PEO/PBT
30/70 showed hardly any degradation at all after this
period. The other copolymers showed an intermediate
degradation which increased with PEO concentration
(Table 1). The mechanism of degradation is still not
completely clear but based on our current knowledge it
seems to comprise at least two factors . The first involves hydrolysis of the polymer matrix which will attack the ester bonds in the polymer. Varying the
PEO/PBT proportion can influence hydrolysis in more
than one way. It will change the amount of available
ester bonds and by increasing the PEO content of the
copolymer it, being a hydrogel, will take up more
water thus facilitating the hydrolysis process. The
second process involves a surface erosion as reported
in this study. Fragmentation initially starts at the
material surface, presumably by mechanical factors,
and then proceeds to the core of the implant. At the
surface of each fragment degradation will continue in
a similar way. The consequence of these two factors
would be that, if an implantation site influences the
polymers accessibility to water or the mechanical fric tion at its surface (i.e., between material and subcutaneous layer), then this might affect the implants degradation rate. Of course, other mechanisms of degradation, such as enzymatic attack, also need to be
investigated.
The degradation and fragmentation of the polymer has consequences for its general biocompatibility .
It was striking to observe that fragmentation led to excessive phagocytosis of fragments by cells that eventually assumed the morphology of foam cells. This indicated that cells could still phagocytose despite the
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14a

14d

b

Figure 14. The interface between bone and different
PEO/PBT proportions. All specimens were decalcified prior to embedding . Note the electron dense
structure at the bone/PEO/PBT interface. An interposed fibrillar zone was always found between bone
matrix and PEO/PBT 30/70. I = implant, b = bone.

14c

a) PEO/PBT 30170, 6 months. Bar

31

= 0.28

µm.

b) PEO/PBT 40/60, 6 weeks. Bar

= 0.37 µm .

c) PEO/ PBT 55/45 , 6 weeks. Bar

= 0.20

µm .

d) PEO/PBT 60/40 , 6 weeks . Bar

= 0.38

µm.

e) PEO/PBT 70/30, 6 weeks . Bar

= 0 .41

µm.
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contact with bone at its interface. All other PEO/PBT
proportions used in this study, that did calcify, did
show such an intimate contact with bone. Furthermore, the relationship between bone-bonding and calcification became clear by two other observations.
First, the materials that showed most calcification
were also characterized by the most bone/biomaterial
contact, although it should be emphasized that this was
only assessed subjectively and needs quantitative support. Second, many sites of intimate contact with
bone were found at sites of copolymer calcification.
Possibly a calcified surface is a preferential site of
bone contact. Further analysis of the non-decalcified
bone/biomaterial interface showed a "continuity" between the hydroxyapatite crystals of bone and the calcium phosphate crystals in the polymer. This continuity might at least partially explain the bonding that occurs at the interface and is not unlike the bonding
mechanism described for both "bioactive" glasses and
ceramics (7, 11, 20, 23, 25, 33].
This similarity between the more traditional
bone-bonding biomaterials and PEO/PBT copolymer
was not confined to the non-decalcified interface but
extended to the decalcified interface as well. Bakker
et al. [3] have described that investigation of the
(H)PEO/PBT copolymer/bone interface revealed a
structure that was similar to the electron dense zone
found for hydroxyapatite ceramic at sites of bone contact. The exact composition of this structure is still
not completely clear but it is composed of organic matrix (rich in glycosaminoglycans) (12], anorganic
material (calcium phosphate crystals) [7], is related to
the lamina limitans of bone (27], and shows some similarities with cement lines and/or reversal lines (14].
Several authors assume that there might be a relationship between the occurrence of bone bonding and the
presence of this particular structure, therefore, it was
interesting to note that the non bone-bonding PEO/
PBT 30/70 did not show such a structure. Furthermore, the morphology of the electron dense zone with
the other polymers was clearly related to the PEO/PBT
proportion. The PEO/PBT 70/30 was characterized by
a multilayered structure clearly penetrating the materials surface whereas the PEO/PBT 40/60 only showed
an electron dense focal deposit. The PEO/PBT 55/45
showed a combination of the previous two polymers in
the shape of both an electron dense deposit, albeit
more continuous, and a multilayered structure. This
difference in morphology of the electron dense layer at
the bone/biomaterial interface seen for PEO/PBT copolymer corresponds with the variations reported for
this structure with calcium phosphate ceramics that
vary in crystal structure [6, 7, 13].
In conclusion, it can be stated that variation in
PEO/PBT proportion will change the degradation rate,
calcification and bone bonding capacity of PEO/PBT
copolymers. Future studies will be directed towards
the quantification of this phenomenon and to investigate whether variations in molecular weight of the

Figures 7, 11, and 12 on color plate, page 33.
Figure 7. Ultrastructural analysis of PEO/PBT calcification. a) Calcified spots as seen by scanning electron microscopy at the surface of a PEO/PBT 70/30
fragment, 3 months after subcutaneous implantation.
Bar = 2 µm. b) A cross-section of spot-like calcified
areas within PEO/PBT 60/ 40 after 1 year subcutaneously. Note the needle-like crystallites. Bar = 1.6
µm. c) Back-scattered electron micrograph of a calcified spot (*) within PEO/PBT 55145 just below the
surface after 3 months of subcutaneous implantation.
Bar = 31.7 µm. d) X-ray map indicating the presence
of calcium in the structure shown in Figure 7c.
Figure 11. a) Back-scattered electron micrograph of
an undecalcified PEO/PBT 60/40 after 3 months implantation. I =implant, b =bone. Bar = 0.6 µm. b
and c) X-ray maps indicating the presence of calcium
(b) and phosphorus (c).
Figure 12. More detailed back-scattered electron micrograph. I =implant, b =bone. Bar = 52 µm. a)
undecalcified PEO/PBT 60/40 after 3 months. b and
c) X-ray map indicating the presence of calcium (b)
and phosphorus (c).

PEO segment will affect the aforementioned properties
in a way similar to variations in PEO/PBT proportion.
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precipitate might then affect the interfacial cellular
phenotype.
With the exception of the release of
terephthalate during degradation, which has been demonstrated, this assumption is up to now purely
hypothetical.

J.M. Sau tier: Different bonding zones are shown at
the transmission electron microscopy (TEM) level.
Do you think that there is a relationship between the
bone-bonding quality and the morphology of the interface? Have you , for example, estimated the bonebonding by pull-out tests?
Authors: We indeed feel that there is a relation between the bone-bonding quality and the morphology of
the interface. Especially in some more recent (unpublished) studies we were well able to demonstrate that
more bone-ingrowth and interfacial contact would be
obtained when using PEO/PBT copolymers that
showed high rates of calcification . Since such polymers also showed a more prominent structure at the
interface with bone , one would tend to think that there
is a relation between interfacial morphology and quality of bonding. Also some recent studies on several
calcium phosphate ceramics were indicative for a delayed appearance of the electron dense structure with
slowly degrading coatings, like fluoroapatite, indicating that a relation with the activity of the ceramic is
indeed present. Concerning the use of pull-out studies , although this seems to be interesting it is actually
quite complicated due to the fact that with different
PEO/PBT proportions the materials will also have different mechanical properties which would make a correct interpretation of pull-out data very complicated, if
possible at all.

J.M. Sautier: Since calcification of the copolymer
occurs in non-osseous sites, do you think that these
materials can be qualified as "osteoinductive"?
Authors: So far we do not have any indications for a
Their
osteoinductive nature of these polymers.
activity seems to be confined to osteoconductivity.
J.M. Sau tier: You clearly demonstrated that PEO/
PBT influenced the degradation rate of the copolymer.
Do you think that these biomaterials could be also
used for clinical application as delivery systems?
Authors: We are currently investigating the potential
of this class of polymers as a drug delivery device.
The first pilot studies indicate that, through some adaptations, these polymers might indeed be a valuable
asset to the already available drug delivery polymers.
T. Kitsugi:
In discussing Figure 12, you state
"Higher magnifications demonstrated that such spots
were composed of needle-like crystals"; this statement
is subjective since there is no evidence. It is very
difficult to define crystals and state their nature from
the morphological observations alone, it is necessary
to use the X-ray diffraction to characterize a crystal!
Authors: To see that the crystals are present (and to
recognize their shape), poses no problem with the
techniques we currently use; determining their nature
is another matter. This is currently the subject of a
different study where we are using X-ray diffraction,
infrared spectroscopy, and high resolution TEM to investigate the crystal structures.

J.M. Sau tier: Calcium absorption by the PEO segment seems to play a role in the calcification of the
polymer, however the mechanism of Ca-P formation is
not clear. In vitro studies could provide, in the future, more information on this process, particularly if
the presence of cell is necessary for polymer calcification.
Authors: We agree with you. Such studies are currently in progress.

T. Kitsugi: It is difficult to conclude degradation
from the observation of the crack since there is a possibility that the crack may have occurred during the
process of making the samples.
Authors: Although this might indeed be a preparation
artefact, it should be realized that it was only found
for this specific PEO/PBT proportion after a specific
post-operative interval. In other words, it is indicative for specific material changes.

J.M. Sautier: When looking at the different morphology of the bone-bonding zone at the TEM level, do
you think there is a relationship between the degradation rate of the polymers and the structure of the electron-dense layer? In this connection, do you think that
degradation of the implant and products released into
tissues will have a biological effect?
Authors: We believe that there exists a relation between calcification and the appearance of the interfacial structure. Since the polymers that show most calcification do also degrade the fastest, there is indeed a
relation, although presumably indirect, between degradation and the occurrence of the electron dense layer.
It might potentially be so that a release of
terephthalate from the polymer during degradation
would , due to a low solubility product, lead to a calcium terephthalate precipitation which might then trigger a further calcium phosphate precipitation. Such a

T. Kitsugi: In Figure 14, it is very hard to distinguish the difference between the various micrographs
showing the electron dense structures at the interfaces
of these PEO/PBT copolymers. Could you please
elaborate on that.
Authors: As explained in Results, there seems to be
a clear trend relating to these electron dense interfacial structures.
Whereas, the structure is very
prominent with a soft material, such as PEO/PBT
70/30, in which case, it even clearly penetrates the
implant surface; it gradually becomes less prominent
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(thinner) when the implant contains more hard segment. Furthermore, with the PEO/PBT 55/45 we see
the appearance of another more electron dense and
floccular material at the interface together with the
structure showing fine granular morphology that characterized the softer materials. With the PEO/PBT
40/60 this floccular material is the only characteristic
interfacial structure in the absence of the finer precipitate.
The micrograph of the PEO/PBT 30/70 (Fig.
14a) deserves a special explanation. First of all this is
from a sample after the 6 month evaluation period in
contrast to the 6 weeks for the other PEO/PBT proportions shown in Figures 14b to 14e. This was so because, before this period, no interfacial contact was
observed between the bone and the implant. Although
at first sight, the structure seems rather similar to that
seen for the PEO/PBT 60/40, it should be noted that it
is composed of very distinct lamellar structures in
comparison to the more granular appearance of the
other structure. In addition, we never found a bone PEO/PBT 30/70 contact with non-decalcified sections
which indicates that this structure is most likely noncalcified.

T. Kitsugi:
Glass-ceramics containing apatite and
wollastonite is now used as an artificial bone in vertebral body. . .. Dr. Kokubo (Kyoto University) published a new coating method of apatite to polymer
[Kokubo T (1992). Bioactivity of glasses and glass ceramics. In: Bone-Bonding Biomaterials. Reed Healthcare Publications, Leiderdorp, Netherlands, 31-46]
Authors: Thank you for your comment.
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